A population study of the long-term consequences of Rose angina: 20-Year follow-up of the Renfrew-Paisley study

Heart

Volumn 92, Issue 12, 2006, Pages 1739-1746

  Murphy, N F ^a   Stewart, S ^b   Hart, C L ^c   MacIntyre, K ^c   Hole, D ^c   McMurray, J J V ^a  

^a WESTERN INFIRMARY   (United Kingdom)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SURVIVAL;

AGE DISTRIBUTION; ANGINA PECTORIS; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; SCOTLAND; SURVIVAL RATE;

EID: 33845202599     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.090118     Document Type: Article

References (46)

1. Lampe FC, Morris RW, Walker M, et al. Trends in rates of different forms of diagnosed coronary heart disease, 1978 to 2000: prospective, population based study of British men. BMJ 2005;330:1046.
2. Kannel WB, Feinleib M. Natural history of angina pectoris in the Framingham Study. Prognosis and survival. Am J Cardiol 1972;29:154-63.
3. Orencia A, Bailey K, Yawn BP, et al. Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death. JAMA 1993;269:2392-7.
4. Hemingway H, Shipley M, Britton A, et al. Prognosis of angina with and without a diagnosis: 11 year follow up in the Whitehall II Prospective Cohort Study. BMJ 2003;327:895.
5. Murabito JM, Evans JC, Larson MG, et al. Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation 1993;88:2548-55.
6. Rose G, Hamilton PS, Keen H, et al. Myocardial ischaemia, risk factors and death from coronary heart-disease. Lancet 1977;1:105-9.
7. Sigurdsson E, Sigfusson N, Agnarsson U, et al. Long-term prognosis of different forms of coronary heart disease: the Reykjavik Study. Int J Epidemiol 1995;24:58-68.
8. Rosengren A, Wilhelmsen L, Hagman M, et al. Natural history of myocardial infarction and angina pectoris in a general population sample of middle-aged men: a 16-year follow-up of the Primary Prevention Study, Goteborg, Sweden. J Intern Med 1998;244:495-505.
9. Lampe FC, Whincup PH, Wannamethee SG, et al. The natural history of prevalent ischaemic heart disease in middle-aged men. Eur Heart J 2000;21:1052-62.
10. Campbell MJ, Elwood PC, Abbas S, et al. Chest pain in women: a study of prevalence and mortality follow up in south Wales. J Epidemiol Community Health 1984;38:17-20.
11. Owen-Smith V, Hannaford PC, Elliott AM. Increased mortality among women with Rose angina who have not presented with ischaemic heart disease. Br J Gen Pract 2003;53:784-9.
12. Hawthorne VM, Watt GC, Hart CL, et al. Cardiorespiratory disease in men and women in urban Scotland: baseline characteristics of the Renfrew/Paisley (midspan) study population. Scott Med J 1995;40:102-7.
13. Hart CL, Watt GC, Davey SG, et al. Pre-existing ischaemic heart disease and ischaemic heart disease mortality in women compared with men. Int J Epidemiol 1997;26:508-15.
14. Stewart S, Hart CL, Hole DJ, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up or the Renfrew/Paisley study. Am J Med 2002;113:359-64.
15. Murphy NF, MacIntyre K, Stewart S, et al. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). Eur Heart J 2005;27:96-106.
16. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:645-58.
17. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977;31:42-8.
18. Bass EB, Follansbee WP, Orchard TJ. Comparison of a supplemented Rose Questionnaire to exercise thallium testing in men and women. J Clin Epidemiol 1989;42:385-94.
19. Blackwelder WC, Kagan A, Gordon T, et al. Comparison of methods for diagnosing angina pectoris: the Honolulu Heart Study. Int J Epidemiol 1981;10:211-15.
20. Heyden S, Bartel AG, Tabesh E, et al. Angina pectoris and the Rose Questionnaire. Arch Intern Med 1971;128:961-4.
21. Simpson RJ Jr, White A. Getting a handle on the prevalence of coronary heart disease. Br Heart J 1990;64:291-2.
22. Prineas RJ, Crow RS, Blackburn H. The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. Boston, MA: John Wright, 1982.
23. World Health Organization. Manual of the international statistical classification of diseases, injuries and causes of death, 9th revision. Geneva: WHO, 1977.
24. Harley K, Jones C. Quality of Scottish Morbidity Record (SMR) data. Health Bull (Edinb) 1996;54:410-17.
25. Daviglus ML, Liao Y, Greenland P, et al. Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study. JAMA 1999;281:530-6.
26. Task Force of the European Society of Cardiology. Management of stable angina pectoris. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 1997;18:394-413.
27. Rosengren A, Hagman M, Pennert K, et al. Clinical course and symptomatology of angina pectoris in a population study. Acta Med Scand 1986;220:117-26.
28. Garber CE, Carleton RA, Heller GV. Comparison of "Rose Questionnaire Angina" to exercise thallium scintigraphy: different findings in males and females. J Clin Epidemiol 1992;45:715-20.
29. Lawlor DA, Adamson J, Ebrahim S. Performance of the WHO Rose Angina Questionnaire in post-menopausal women: are all of the questions necessary? J Epidemiol Community Health 2003;57:538-41.
30. Eriksson SV, Bjorkander I, Held C, et al. Age and gender differences in left ventricular function among patients with stable angina and a matched control group. A report from the Angina Prognosis Study in Stockholm. Cardiology 1996;87:287-93.
31. Rose G. Variability of angina. Some implications for epidemiology. Br J Prev Soc Med 1968;22:12-15.
32. Bodegard J, Erikssen G, Bjornholt JV, et al. Possible angina detected by the WHO Angina Questionnaire in apparently healthy men with a normal exercise ECG: coronary heart disease or not? A 26 year follow up study. Heart 2004;90:627-32.
33. Cook DG, Shaper AG, Macfarlane PW. Using the WHO (Rose) Angina Questionnaire in cardiovascular epidemiology. Int J Epidemiol 1989;18:607-13.
34. LaCroix AZ, Guralnik JM, Curb JD, et al. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation 1990;81:437-46.
35. Smith WC, Kenicer MB, Tunstall-Pedoe H, et al. Prevalence of coronary heart disease in Scotland: Scottish Heart Health Study. Br Heart J 1990;64:295-8.
36. Murphy NF, Simpson CR, MacIntyre K, et al. Prevalence, incidence, primary care burden and medical treatment of angina in Scotland: age, sex and socioeconomic disparities - a population based study Heart 2006;92:1047-54.
37. The ALLHAT Officers and Coordinators, for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
38. Pedersen TR, Kjekshus J, Berg K, et al. Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation 1996;93:1796-802.
39. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.
40. The IONA Study Group. Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 2002;359:1269-75.
41. Braunwald E, Domanski MJ, Fowler SE, et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004;351:2058-68.
42. Poole-Wilson PA, Lubsen J, Kirwan BA, et al. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial. Lancet 2004;364:849-57.
43. Richards H, McConnachie A, Morrison C, et al. Social and gender variation in the prevalence, presentation and general practitioner provisional diagnosis of chest pain. J Epidemiol Community Health 2000;54:714-18.
44. Gardner K, Chapple A. Barriers to referral in patients with angina: qualitative study. BMJ 1999;319:418-21.
45. Capewell S, Pell JP, Morrison C, et al. Increasing the impact of cardiological treatments. How best to reduce deaths. Eur Heart J 1999;20:1386-92.
46. Mukherjee D, Fang J, Chetcuti S, et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004;109:745-9.